10 Best Performing NASDAQ Stocks According to Wall Street Analysts
On April 28, Tom Lee of Fundstrat joined CNBC's 'Power Lunch' to discuss the outlook for equity markets.
Immix Biopharma Inc. (IMMX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Saturn V Capital Management Xiaoying Tian | 3,693,585 | $33,648,559 | +24% | 6.09% |
| 2. | Millennium Management Israel Englander | 1,750,200 | $15,944,322 | +6% | 0.01% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,641,552 | $14,954,538 | -18% | 0.01% |
| 4. | Logos Capital Arsani William | 1,225,000 | $11,159,750 | +23% | 0.56% |
| 5. | Velan Capital Adam Morgan | 740,000 | $6,741,400 | +2015% | 4.22% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.67 | 746 | $4,975.82 | 1,141,683 | 2025-12-10 | Filing | |
| $6.58 | 770 | $5,066.60 | 291,429 | 2025-12-10 | Filing | |
| $2.02 | 2,500 | $5,050.00 | 1,140,937 | 2025-09-17 | Filing | |
| $1.97 | 2,600 | $5,122.00 | 290,659 | 2025-09-16 | Filing | |
| $2.30 | 2,178 | $4,998.51 | 1,138,437 | 2025-06-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.75 | 200 | $550.00 | 899,800 | 2022-07-14 | Filing | |
| $2.75 | 200 | $550.00 | 899,800 | 2022-07-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,802,002 | $43,698,218 | 0.02% | |
| 2. | 2,549,019 | $23,221,563 | 0.38% | |
| 3. | 1,787,994 | $16,288,625 | 0% | |
| 4. | 1,000,000 | $9,110,000 | 1.57% | |
| 5. | 969,066 | $8,828,191 | 0% |
News See All
H.C. Wainwright Reiterates Buy Rating on Immix Biopharma (IMMX) Following Promising Interim Results from NXC-201 Trial
On June 4, analyst Robert Burns of H.C. Wainwright reiterated a Buy rating on Immix Biopharma, Inc. (NASDAQ:IMMX) with a price target of $7.00.
Immix Biopharma's NXC-201 Achieves 70% Complete Response Rate in AL Amyloidosis Trial
On Tuesday, Immix Biopharma Inc.
10 Best Penny Stocks to Buy and Hold According to Reddit
In this article, we will discuss the 10 best penny stocks to buy and hold according to Reddit.